Modern Healthspan: Should You Take a Multivitamin? A Harvard Researcher’s Verdict

🟢
Peer-Reviewed Research
M
Modern Healthspan

Video Summary · April 19, 2026

View Full Protocol →

Key Takeaways

  • Consider a multivitamin as an affordable insurance policy against potential nutritional deficiencies.
  • Choose a simple, basic multivitamin over specialized formulations for general coverage.
  • Monitor nutritional biomarkers through regular blood tests to identify deficiencies or insufficiencies.
  • Focus on a healthy diet as the primary defense for extending healthspan, supplementing only when necessary.
  • Individuals with accelerated epigenetic aging or existing health risk factors may benefit more from multivitamin use.

Supplements & Protocols Mentioned

  • Multivitamin: A basic, non-specialized formulation is recommended.
  • Vitamin B12: Particularly important for older adults to prevent deficiency.
  • Carotenoids: Levels can increase with multivitamin use.
  • 25-hydroxy D: Multivitamins with 1000 IU can raise levels if low.

Notable Quotes

“A multivitamin is like an insurance policy—it’s inexpensive compared to testing for deficiencies.”

“For individuals with accelerated epigenetic aging, multivitamins may delay the increase in aging trajectories.”

Bottom Line

If you suspect nutritional deficiencies or have accelerated epigenetic aging, consider taking a simple multivitamin while prioritizing a healthy diet and regular biomarker monitoring.

Explore supplements mentioned in this video

Shop on iHerb →

Explore More

Watch the Full Video

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

From Our Research Network

Part of the Evidence-Based Research Network

Similar Posts